MIA Blog Archives

If I thought that it was possible, I would have opened a string of clinics all over the country to help get people off of antidepressants.  Unfortunately, the problems that sometimes occur when people try to stop an SSRI antidepressant are much more severe and long-lasting than the medical profession acknowledges, and there is no antidote to these problems. The truth is, giving people information about taking antidepressants is like giving information to people who are enroute to a casino; they go because they hear that some people win (at least for a time), but the losers are the ones who ultimately pay for it all — and the odds are not in their favor.

After long-term use, most people are going to have serious symptoms when stopping SSRIs. Many people are going to have transient, mild to moderate difficulty and some are going to end up falling down the akathisia rabbit hole. That is a long, difficult drop.

The conventional wisdom is that antidepressant medications are effective and safe. However, the scientific literature shows that the conventional wisdom is flawed. While all prescription medications have side effects, antidepressant medications appear to do more harm than good as treatments for depression.

In the wake of the new study by Dutch researcher Lex Wunderink, it is time for psychiatry to do the right thing and acknowledge that, if it wants to do best by its patients, it must change its protocols for using antipsychotics. The current standard of care, which—in practice—involves continual use of antipsychotics for all patients diagnosed with a psychotic disorder, clearly reduces the opportunity for long-term functional recovery.

Three recently published papers, along with a report by a Minnesota group on health outcomes in that state, provide new reason to mull over...

The New Yorker's story on Laura Delano and psychiatric drug withdrawal is a glass-half-full story: It addresses a problem in psychiatry and yet hides the deeper story to be told. A story of how her recovery resulted from seeing herself within a counter-narrative that tells of the harm that psychiatry can do.

The United States desperately needs good programs to help people withdraw from neuroleptic drugs. From all I have seen and heard, there aren’t any - none at least that can reputably claim to get good results on a fairly consistent basis. Again and again I find myself challenged to envision such a program, and in reply to the challenge I have broken down this hypothetical program into various components.

When the benzodiazepines were first introduced, it was widely claimed, both by psychiatrists and by pharma, that they were non-addictive. This claim was subsequently abandoned in the face of overwhelming evidence to the contrary, and the addictive potential of these products is now recognized and generally accepted.

Depression during pregnancy is an important issue. Depression should not be ignored and depressed pregnant women deserve good treatment and care. Part of that good care, though, is providing them with full and correct information. I care for pregnant women taking antidepressants on a daily basis and too often they tell me that the only counseling they received about the medication was, “my doctor told me it’s safe in pregnancy.” This post will review the evidence in this area and address the counterarguments.

My study, in which I slowly withdrew people from prescribed antipsychotics and antidepressants, found that it is possible to decrease both spending on psychiatric drugs and patients' chronic exposure to them. In general, the drug-reduction process was well-tolerated and well-accepted among those treated.

Psychiatric meds can shut down the emotions and consciousness enough to make it possible to tolerate dynamics that would inspire rage or surges of empowered activity without the meds. It can be helpful to look closely at these blocks and start to create a map to freedom, understanding that it is a complex process that involves not only the physiology of the body of the individual taking meds, but the architecture of the social system around that person.

Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.

Antidepressant withdrawal is no longer an unknown disorder since knowledge on this topic has grown enough to be translated into practice. As proposed by George Engel in 1977, medical doctors, including psychiatrists, can observe and listen to their patients and develop a program to treat withdrawal and restore health.

While increasing numbers of Americans are being prescribed antidepressants, the Centers for Disease Control reports that suicide rates increased 28% from 1999 to 2010. Trained professionals remain unable to predict who is at risk. Their guess is as good as chance.

The phrase "medication tapering" is being used more and more as the preferred term for the psychiatric medication withdrawal or coming off process. Based on my years of work educating many people around coming off medications -- clients, support groups, and in workshops and trainings -- I think that term is misleading, and let me explain why.

Martin Harrow and Thomas Jobe have a new article coming out in Schizophrenia Bulletin that I wish would be read by everyone in our society with an interest in “mental health.” Harrow and Jobe, who conducted the best study of long-term schizophrenia outcomes that has ever been done, do not present new data in this article, but rather discuss the central question raised by their research: Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? Or does it hinder it?

Online communities are stepping in to help people facing withdrawal effects amass information and receive support for their withdrawal experiences.

Our main reason for beginning an awareness month is the need for recognition-- a yearning to make the word “iatrogenic” and its corresponding language available to our community, and to the greater public as a household name. We don’t have the luxury of raising money for research, racing for the cure, or ribbons. For that we would have to be on the map. Why is it that something this pervasive gets so little traction?

There are a vast number of studies that document the diverse range of side effects caused by antipsychotic drugs. These adverse effects include brain...

The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.

Published in the peer-reviewed journal Advances in Mind Body Medicine, this case series is the first of its kind to document the methodology employed in the successful discontinuation of a range of psychotropic medications, with holistic support interventions providing long-term mood support.

We held the first course ever on psychiatric drug withdrawal on 12 June 2017 in Copenhagen. The course was open to patients, relatives, psychologists, doctors and other social and healthcare workers, and 77 people participated.

Peter Gøtzsche and Anders Sørensen on trying to get a review of methods for safe antidepressant withdrawal published in Cochrane: "They sent us on a mission that was impossible to accomplish" to "protect the psychiatric guild."

If academic psychiatry is evidence-based, why did it take two decades to recognize SSRI withdrawal as widespread and chronic among patients?

Dutch investigators will soon publish an article in Neurochemistry International that sheds light on how SSRI antidepressants affect the serotonergic system over the longer...